Overview

Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
0
Participant gender:
Female
Summary
The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
hany farouk
Treatments:
Misoprostol
Criteria
Inclusion Criteria:

- All women above 18 years of age

- Less than 12 weeks of gestation.

- Pregnancy is confirmed by pregnancy test or ultrasound scan.

- missed abortion

- Normal general and gynecological examination.

Exclusion Criteria:

- Hemodynamically unstable.

- Suspected sepsis with temperature 38 °C.

- Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism,

- respiratory illnesses, recent liver disease, or pruritus of pregnancy.

- Presence of intrauterine contraceptive device (IUCD).

- Suspect or proven ectopic pregnancy.

- Failed medical or surgical evacuation before the presentation.

- Known allergy to misoprostol.